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PERK regulates Gq protein-coupled
intracellular Ca2+ dynamics in primary
cortical neurons
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Abstract
PERK (EIF2AK3) is an ER-resident eIF2α kinase required for behavioral flexibility and metabotropic glutamate
receptor-dependent long-term depression via its translational control. Motivated by the recent discoveries that PERK
regulates Ca2+ dynamics in insulin-secreting β-cells underlying glucose-stimulated insulin secretion, and modulates
Ca2+ signals-dependent working memory, we explored the role of PERK in regulating Gq protein-coupled Ca
2+
dynamics in pyramidal neurons. We found that acute PERK inhibition by the use of a highly specific PERK inhibitor
reduced the intracellular Ca2+ rise stimulated by the activation of acetylcholine, metabotropic glutamate and
bradykinin-2 receptors in primary cortical neurons. More specifically, acute PERK inhibition increased IP3 receptor
mediated ER Ca2+ release, but decreased receptor-operated extracellular Ca2+ influx. Impaired Gq protein-coupled
intracellular Ca2+ rise was also observed in genetic Perk knockout neurons. Taken together, our findings reveal a
novel role of PERK in neurons, which is eIF2α-independent, and suggest that the impaired working memory in
forebrain-specific Perk knockout mice may stem from altered Gq protein-coupled intracellular Ca
2+ dynamics in
cortical pyramidal neurons.
Keywords: PERK, Gq protein-coupled receptor, Ca
2+, Receptor-operated Ca2+ entry
Introduction
Calcium (Ca2+) serves as an important second messen-
ger in the central nervous system, as it regulates various
neuronal processes including neurotransmitter release,
synaptic plasticity, neuron excitability, and neuronal
gene transcription [1]. Initiators of intracellular Ca2+ rise
in neurons include the Gq-protein coupled receptors,
whose activation upon agonist binding leads to the acti-
vation of Gq/phospholipase C (PLC) pathway. Activated
PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate
(PIP2) resulting in the generation of inositol 1,4,5-tri-
phosphate (IP3) and diacylglycerol (DAG). While the
increased cytosol IP3 induces internal Ca
2+ release by
binding with ER resident inositol-1,4,5-triphosphate re-
ceptor (IP3R), the activation of Gq/PLC cascade further
stimulates receptor-operated Ca2+ influx from external
space.
The central nervous system expresses a variety of Gq
protein-coupled receptors including the M1 and M3
muscarinic acetylcholine receptors (mAChR), the group
1 metabotropic glutamate receptor (mGluR1), and the
bradykinin-2 receptor [2, 3]. Gq protein-coupled intra-
cellular Ca2+ dynamics has been shown to play promin-
ent roles in a number of neuronal processes. For
example, in pyramidal neurons, Gq protein-coupled
intracellular Ca2+ rise induced by mAChR or mGluR1
activation is required for the induction of Ca2+-activated
nonselective cationic current (ICAN) [4, 5], which is
considered the ionic mechanism underlying persistent
neuronal firing essential for working memory. In cere-
bellar Purkinje cells, mGluR1-induced postsynaptic Ca2+
rise in dendritic spines has been shown to be essential
for long-term synaptic depression [6].
PERK, an eIF2α kinase well known for its role in eIF2α-
dependent protein synthesis and translational control, has
been shown to modulate Ca2+ dynamics-dependent work-
ing memory [7], in addition to protein synthesis-
dependent cognitive functions including learning and
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memory flexibility [8], and long-term depression medi-
ated by mGluR1 [9]. Moreover, it has been demon-
strated that PERK acutely regulates Ca2+ dynamics in
β-cells underlying glucose-stimulated insulin secretion,
which is independent on protein synthesis [10]. Consider-
ing the critical role of Ca2+ signaling in working memory,
we hypothesized that PERK may also regulate Ca2+ dy-
namics in pyramidal neurons. We show herein that acute
PERK inhibition impairs Gq protein-coupled intracellular
Ca2+ rise. More specifically, PERK inhibition enhances
IP3R mediated ER Ca
2+ release, but suppresses receptor-
operated external Ca2+ influx. Gq protein-coupled intra-
cellular Ca2+ rise is also impaired in genetic Perk knockout
neurons. Taken together, our findings suggest that PERK
regulates Gq protein-coupled Ca
2+ dynamics in pyramidal
neurons, which may serve as the cellular mechanism
underlying impaired working memory in forebrain-
specific Perk knockout mice.
Methods
Reagents
PERK inhibitor GSK2606414 was a kind gift from
Jeffery M. Axten and Rakesh Kumar, GlaxoSmithKline,
Collegeville, PA. (S)-3,5-Dihydroxyphenylglycine (DHPG)
and thapsigargin were purchased from Tocris, bradykinin
acetate salt was purchased from Sigma, carbachol was
purchased from EMD Millipore, and Bt3-Ins(1, 4, 5)P3/
AM (IP3-AM) was purchased from SiChem.
Primary neuron culture
Wild-type primary cortical neurons were prepared from
wild-type mice colony in C57BL/6 J background as
previously described [7]. Briefly, the cerebral cortex was
isolated from day 0 pups and dissociated in 0.05 %
trypsin-EDTA with DNase1 for 30 min at 37 °C (5 %
CO2), followed by two washes with HBSS containing
10 % FBS and trituration in neuronal medium with
DNase1. Dissociated cells were collected by centrifuga-
tion at 120Xg for 5 min and plated on glial-coated
12 mm glass coverslips in a 24-well plate at a density of
approximately 150,000 cells per well. Total medium was
changed on the 1st day in vitro (DIV) and 50 % of the
medium was changed on DIV 3 and DIV 5. Genetic Perk
knockout neurons were prepared from Perk-floxed
Nestin-Cre mice in the same way, and the genotype of
each pup was determined later. The cells were main-
tained in MEM based neuronal medium containing 5 %
FBS (GEMINI Bio-Products), 2 % B27 (Invitrogen),
1 mM L-Glutamine (Gibco), 20 mM D-Glucose, 2 μM
Cytosine Arabinoside (AraC), 40 units/ml penicillin,
40 μg/ml streptomycin and 100 ng/ml Amphotericin B,
and final pH was adjusted to 7.4 with NaHCO3 (100 mg/
500 ml). DIV 14–19 neurons were used for Ca2+ imaging
experiments and immunocytochemistry.
Intracellular Ca2+ measurements and Ca2+ imaging data
analysis
Intracellular Ca2+ levels were measured using the ratio-
metric Ca2+ probe Fura-2 AM (Molecular Probes).
Briefly, coverslips seeded with neurons at DIV 14–19
were incubated in bath solution with 2 μM Fura-2-AM
for 30 min at room temperature in the dark. Coverslips
were then transferred to fresh bath for 15 min to allow
the cleavage of AM esters by cellular esterases. After dye
loading, the coverslips were put in a perfusion chamber
mounted on Nikon TE-200-S inverted microscope with
Xenon arc lamp as the fluorescence excitation source.
Ratios of images with the fluorescent emission signal
excited at 340 nm over 380 nm were obtained using an
excitation filter wheel (340 nm/380 nm, Chroma Tech-
nology) and UV-2A filter cube (Nikon). Images were
collected every 5 sec using a 20X objective and a cooled
charge-couple device (CCD) camera. SimplePCI imaging
software was used for the control of filter wheel and col-
lection of data. Tyrode’s solution (123 mM NaCl,
30 mM Glucose, 25 mM HEPES, 5 mM KCl, 2 mM
CaCl2 and 1 mM MgCl2) mimicking cerebrospinal fluid
was used as bath solution and the pH was adjusted to
7.4 before each experiment. Cells were perfused with
the bath solution at the constant rate of 1 drop/2 sec
during Ca2+ imaging process, and this rate was also used
for the application of different drugs as described in fig-
ure legends. Triangular shaped pyramidal neurons were
selected for imaging and the soma was selected as the
region of interest. Sister coverslips from 2 to 3 inde-
pendent cultures were used for each experiment, and
pooled data was analyzed.
Ca2+ imaging measurements were analyzed by calculat-
ing the area under the curve (AUC). Due to the inherent
variation of primary neuron culture, a small percentage of
neurons displayed high Ca2+ transients, which obscured
the drug-stimulated intracellular Ca2+ rise. For this reason,
basal Ca2+ transients over 100 sec were analyzed, and those
with AUC >2 (<5 %) were excluded from the final analysis.
Western blot analysis
To determine PERK knockdown efficiency in genetic
Perk knockout neurons, mouse cerebral cortex was
isolated from day 0 Perk-floxed Nestin-Cre pups, and
homogenized mechanically in ice-cold buffer (100 mM
HEPES, 1 mM EDTA, 2 mM EGTA, 0.5 mM DTT, sup-
plemented with 1X protease inhibitor and 1X phosphat-
ase inhibitor cocktails; pH was adjusted to 7.0 before
use) using a polypropylene pestle. Tissue lysates for
western blot were prepared using RIPA buffer with 1X
protease inhibitor and 1X phosphatase inhibitor cock-
tails. Samples were denatured by boiling in 2X Laemmli
buffer for 5 min. The following primary antibodies were
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used in western blot analysis: monoclonal rabbit anti-
PERK (Cell Signaling), monoclonal mouse anti-β-actin
(GenScript).
Synapse formation analysis
Immunocytochemical detection of the presynaptic
marker Synapsin 1 and dendritic marker MAP2 was
used to visualize synapses. Neurons seeded on glial-
coated coverslips were fixed with 4 % paraformaldehyde,
4 % sucrose in PBS for 15 min at room temperature,
permeabilized with 0.3 % Triton X-100 in PBS for
10 min, and blocked with 5 % horse serum (Invitrogen)
in PBS containing 0.1 % Triton X-100 for 1 h. The cells
were then incubated with the mixture of following pri-
mary antibodies overnight at 4 °C: mouse anti-Synapsin
1 (Chemicon), rabbit anti-MAP2 (Millipore). Appropri-
ate secondary antibodies conjugated with Alexa Fluor
546 or 488 (Molecular Probes) were applied for 1 h to
visualize the signals. The coverslips were mounted using
the anti-fade reagent with DAPI (Molecular Probes).
The fluorescent images were captured at 40X with con-
sistent fluorescent intensities using Nikon Eclipse E1000
and SPOT 5.1 software.
To compare synapse formation density between wild-
type and Perk knockout neurons, Synapsin 1 positive
puncta in contact with MAP2 labeled dendrites within
middle basal dendrites were counted, and the dendrite
length was measured using ImageJ.
Additional information regarding the protocols used
in the supplemental figures is provided in (Additional
file 1.
Results
Acute PERK inhibition impairs Gq protein-coupled
intracellular Ca2+ rise in primary cortical neurons
To acutely inhibit PERK enzyme activity in primary
cortical neurons, we took advantage of a highly specific
inhibitor of PERK, GSK2606414 (PERKi), which acts by
competing for the ATP binding domain in the catalytic
site [11]. Previously we have shown that 500 nM PERKi
pretreatment for 15 min sufficiently abolishes thapsigar-
gin induced PERK activation and eIF2α phosphorylation
in primary neurons [7]. In addition, it has been shown
by others that 500 nM PERKi pretreatment fully inhibits
PERK enzyme activity in a variety of cell types [11, 12].
Taken together, the above results suggest that 500 nM of
the PERKi is effective in acute PERK inhibition.
At the gross subcellular level PERK has been shown to
be expressed in both cell body and dendrites [9]. To deter-
mine if PERK is also present in the proximate region of the
synapse, we examined isolated synaptoneurosomes from
wild-type mouse prefrontal cortex and found that PERK
was indeed present there (Additional file 2: Figure S1).
Therefore PERK is available for participating in the
molecular processes that govern synaptic plasticity.
To examine if acute PERK inhibition impairs Gq
protein-coupled intracellular Ca2+ ([Ca2+]i) rise, an intra-
cellular response which is closely related to working
memory, we used Fura-2 AM to visualize [Ca2+]i dynam-
ics in primary cortical neurons. We first tested if PERKi
impacts cholinergic activation induced [Ca2+]i rise by
treating neurons with 250 μM carbachol, and found that
15 min 500 nM PERKi pretreatment significantly re-
duced carbachol-induced [Ca2+]i rise (Fig. 1a). The
acetylcholine receptor agonist, carbachol, activates both
muscarinic acetylcholine and nicotinic acetylcholine
receptors with the former being a Gq protein-coupled
receptor, and the latter a Ca2+-permeable ionotropic
receptor [13]. Thus the carbachol-induced [Ca2+]i rise
can be attributed to the stimulation of either receptor.
To further examine how PERK inhibition impacts Gq
protein-coupled intracellular Ca2+ signaling, we tested
another Gq protein-coupled receptor, mGluR1, by the
use of its specific agonist, DHPG. Again, acute PERK in-
hibition significantly suppressed 50 μM DHPG induced
[Ca2+]i rise (Fig. 1b). We also tested a third Gq protein-
coupled receptor, the bradykinin-2 receptor, using its
specific agonist, bradykinin, and found that 1 μM brady-
kinin induced [Ca2+]i increase was almost abolished by
PERKi treatment (Fig. 1c). That PERK inhibition is able
to block cytosolic Ca2+ influx stimulated by three differ-
ent Gq protein-coupled receptors strongly argues that
PERKi impacts the Gq/PLC pathway at a point down-
stream of receptor binding. Since PERK is present in
dendrites in addition to cell body, we examined if
PERK also regulates Gq protein-coupled Ca
2+ rise in
proximal dendrites. Indeed, acute PERK inhibition im-
pairs DHPG-stimulated Ca2+ rise in proximal dendrites
(Additional file 3: Figure S2).
IP3-AM induced [Ca
2+]i rise is impaired by acute PERK
inhibition
Receptor-simulated activation of the Gq/PLC pathway
produces IP3 and increases [Ca
2+]i by induction of
IP3 receptor mediated ER Ca
2+ release and receptor-
operated Ca2+ influx. To determine if PERKi affects PLC
activity or a downstream Ca2+ channel, IP3-AM induced
[Ca2+]i rise was examined in PERK-inhibited neurons
and DMSO controls. Cell permeable IP3-AM induced a
delayed but sustained [Ca2+]i rise in DMSO controls
(Fig. 2). The delayed response likely reflects the time re-
quired to remove the AM moiety by cellular esterases.
Acute PERK inhibition substantially suppressed IP3-AM
induced [Ca2+]i rise which does not require PLC activity,
indicating that the likely target for PERKi is a down-
stream Ca2+ channel rather than PLC.
Zhu et al. Molecular Brain  (2016) 9:87 Page 3 of 11
Fig. 2 IP3-AM induced intracellular Ca
2+ ([Ca2+]i) rise is impaired by acute PERK inhibition. [Ca
2+]i. of primary cortical neurons in response to 1 μM
IP3-AM treatment (DMSO n = 48, PI n = 48; *** p < 0.001, two-tailed student’s t-Test). Cells were pretreated with 500 nM PERK inhibitor (PI) or
DMSO for 15 min before recording. In the representative graph on the left, each Ca2+ trace represents the average of 12–14 neurons that were
imaged from the same coverslip. Basal Ca2+ oscillation over 100 sec before treatment and IP3-AM-stimulated [Ca
2+]i rise over 600 sec were
quantified by calculating the area under the curve (AUC). Final analysis is presented as AUC/100 sec and shown in the bar graph on
the right
Fig. 1 Gq protein-coupled intracellular Ca
2+ ([Ca2+]i) rise is impaired by acute PERK inhibition. a [Ca
2+]i of primary cortical neurons in response to
250 μM carbachol treatment (DMSO n = 21, PI n = 17; ***p < 0.001, two-tailed student’s t-Test). b [Ca2+]i of primary cortical neurons in response
to 50 μM DHPG treatment (DMSO n = 36, PI n = 57; ***p < 0.001, two-tailed student’s t-Test). c [Ca2+]i of primary cortical neurons in response to
1 μM bradykinin treatment (DMSO n = 25, PI n = 37; ***p < 0.001, two-tailed student’s t-Test). In all of the experiments above, cells were pretreated
with 500 nM PERK inhibitor (PI) or DMSO for 15 min before recording. In the representative graph on the left, each Ca2+ trace represents the
average of 6–11 neurons that were imaged from the same coverslip. Basal Ca2+ oscillation over 100 sec before treatment and drug-stimulated
[Ca2+]i rise over 200 sec were quantified by calculating the area under the curve (AUC). Final analysis is presented as AUC/100 sec and shown in
the bar graph on the right
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Acute PERK inhibition increases IP3 receptor mediated ER
Ca2+ release
Two sources of Ca2+ influx contribute to Gq protein-
coupled [Ca2+]i increase: IP3R mediated ER Ca
2+ release
and receptor-operated Ca2+ entry (ROCE) from extracel-
lular medium. To study PERKi’s effect on internal Ca2+ re-
lease, we measured [Ca2+]i rise upon carbachol treatment
in the absence of extracellular Ca2+, to exclude any contri-
bution from nicotinic acetylcholine receptor or receptor-
operated Ca2+ channel (ROCC)-dependent Ca2+ influx.
Cells were perfused with Ca2+-free bath for 100 sec before
stimulation with 250 μM carbachol. Carbachol treatment
in Ca2+-free bath triggered a transient and small [Ca2+]i
increase due to Ca2+ release from intracellular stores,
which was significantly higher in PERK-inhibited neurons
(Fig. 3a). The experiment was repeated using 50 μM
DHPG to stimulate mGluR1 and similar result was ob-
tained (Fig. 3b). Taken together, these results suggest that
acute PERK inhibition increases IP3R mediated ER Ca
2+
release.
Acute PERK inhibition impairs receptor-operated Ca2+
entry, but not store-operated Ca2+ entry
Our observation that acute PERK inhibition impairs Gq
protein-coupled [Ca2+]i mobilization and increases IP3R-
dependent ER Ca2+ release suggests that ROCE is
impaired as a result of PERKi treatment. To test this
hypothesis, DHPG stimulated ROCE was examined in
PERK-inhibited neurons and DMSO controls after ER
Ca2+ depletion by the use of a SERCA pump inhibitor,
thapsigargin [14]. The pretreatment with thapsigargin
caused a rapid and irreversible depletion of ER Ca2+.
Thus upon DHPG stimulation, the rise of [Ca2+]i in ER
Ca2+ depleted-neurons was largely contributed by
ROCC-dependent extracellular Ca2+ influx. PERKi treat-
ment significantly reduced DHPG induced [Ca2+]i rise in
ER Ca2+ depleted-neurons, indicating that ROCC-
dependent extracellular Ca2+ influx is impaired upon
PERK inhibition (Fig. 4a).
Store-operated Ca2+ entry (SOCE) refers to cytosol
Ca2+ influx mediated by cell membrane Ca2+ channels
triggered by ER Ca2+ store depletion. Since ROCE and
SOCE are two closely related processes, and store deple-
tion is an integral component of ROCE, we next exam-
ined PERKi’s effect on SOCE in primary cortical
neurons. As shown in Fig. 4a, in neurons perfused with
Ca2+-containing bath, thapsigargin treatment only elic-
ited a transient [Ca2+]i rise, which is the result of the
combined effect of thapsigargin-induced ER Ca2+ release
and SOCE, suggesting that thapsigargin stimulation
alone did not significantly induce SOCE in primary neu-
rons. To maximally activate SOCE, we followed a “Ca2+
re-addition” protocol [15], where cells were treated with
1 μM thapsigargin in Ca2+-free bath for 300 sec to fully
deplete ER Ca2+ and activate store-operated Ca2+ chan-
nels (SOCC). Subsequent reintroduction of 2 mM Ca2+
Fig. 3 Acute PERK inhibition increases IP3 receptor mediated ER Ca
2+ release. a [Ca2+]i. of primary cortical neurons in response to 250 μM
carbachol treatment in Ca2+ free bath (DMSO n = 29, PI = 26; * p < 0.05, two-tailed student’s t-Test). b [Ca2+]i. of primary cortical neurons in
response to 50 μM DHPG treatment in Ca2+- free bath (DMSO n = 33, PI = 39; * p < 0.05, two-tailed student’s t-Test). In both experiments, cells
were pretreated with 500 nM PERK inhibitor (PI) or DMSO for 15 min before recording. Drug treatment started 100 sec after Ca2+- free bath perfu-
sion. In the representative graph on the left, each Ca2+ trace represents the average of 8–12 neurons that were imaged from the same coverslip.
Basal Ca2+ oscillation over 100 sec before treatment and drug-stimulated [Ca2+]i rise over 20–30 sec were quantified by calculating the area under
the curve (AUC), and shown in the middle and right bar graphs respectively
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into the bath elicited a sustained [Ca2+]i elevation,
reflecting SOCC mediated Ca2+ influx. No difference
was observed between PERK-inhibited neurons and
DMSO controls (Fig. 4b), suggesting that acute PERK in-
hibition does not affect SOCE. Previous studies have
shown that thapsigargin induced SOCE in pyramidal
neurons is L-type voltage-gated Ca2+ channel (VGCC)-
independent [16], thus L-type VGCC inhibitor was not
included in the bath.
Gq protein-coupled [Ca
2+]i rise is impaired in genetic Perk
knockout primary cortical neurons
To investigate if the impaired Gq protein-coupled [Ca
2+]i
mobilization could be mimicked by genetic ablation of
Perk, primary cortical neurons from brain-specific Perk
KO (BrPKO) mice were examined. BrPKO mice were
generated by crossing Perk-floxed mice [17] with the
transgenic Nestin-Cre mice strain [18], which enables
widespread deletion of the loxP-flanked Perk gene se-
quence in neurons and glial cells during embryonic stage
[19, 20]. Western blot analysis confirmed almost
complete knockdown of PERK in the cerebral cortex of
BrPKO mice at postnatal day 0 (Fig. 5a). With the con-
cern that knockdown of PERK may affect neuronal dif-
ferentiation and synapse formation in vitro, synapse
density was examined in BrPKO and wild-type primary
cortical neurons by double immunofluorescence staining
of the presynaptic marker Synapsin 1 and the dendritic
marker MAP2 prior to examining their Gq protein-
coupled [Ca2+]i rise. No significant difference was ob-
served in synapse density between genotypes (Fig. 5b).
To determine if Gq protein-coupled [Ca
2+]i mobilization
is impaired in BrPKO primary cortical neurons, mGluR1
agonist DHPG was applied, and significantly smaller
DHPG-stimulated [Ca2+]i rise was observed in BrPKO
neurons (Fig. 5c), which is consistent with the pharma-
cological PERK inhibition results.
Discussion
Although earlier studies have demonstrated that PERK
plays an important role in regulating cognitive functions
including behavior flexibility [8] and mGluR1-dependent
long-term depression [9], the underlying mechanisms re-
main unknown. Previously we showed that PERK regu-
lates Ca2+ dynamics in electrically excitable pancreatic β
cells [10], and modulates Ca2+ dynamics-dependent
working memory [7], suggesting that PERK may regulate
Ca2+ dynamics in neurons. Neuronal cytosolic Ca2+ rise
is contributed by two major Ca2+ sources: internal Ca2+
release mediated by ER-resident IP3R or Ryanodine re-
ceptor, and external Ca2+ influx mediated by voltage-
dependent Ca2+ channel, ionotropic glutamate receptor,
Fig. 4 Acute PERK inhibition impairs receptor-operated Ca2+ entry, but not store-operated Ca2+ entry. a [Ca2+]i. of thapsigargin (TG) pretreated
primary cortical neurons in response to 50 μM DHPG treatment. Cells were pretreated with 500 nM PERK inhibitor (PI) or DMSO for 15 min before
recording, and perfused with 1 μM TG for 300 sec before 50 μM DHPG treatment. In the representative graph on the left, each Ca2+ trace repre-
sents the average of 8–9 neurons that were imaged from the same coverslip. Basal Ca2+ oscillation over 100 sec before treatment and DHPG-
stimulated [Ca2+]i rise over 500 sec were quantified by calculating the area under the curve (AUC). Final analysis is presented as AUC/100 sec and
shown in the bar graph on the right (DMSO n = 37, PI n = 35; *** p < 0.001, two-tailed student’s t-Test). b Store-operated Ca2+ entry in primary
cortical neurons. Cells were pretreated with 500 nM PI or DMSO for 15 min before recording, and perfused with 1 μM TG in Ca2+- free
bath for 300 sec before reintroduction of 2 mM Ca2+. In the representative graph on the left, each Ca2+ trace represents the average of 9–12 neurons
that were imaged from the same coverslip. Store-operated Ca2+ entry over 500 sec was quantified by calculating the area under the curve (AUC). Final
analysis is presented as AUC/100 sec and shown in the bar graph on the right (DMSO n = 45, PI n = 36; n.s. not significant, two-tailed student’s t-Test)
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nicotinic acetylcholine receptor, or TRPCs [21]. PERK’s
subcellular localization in the soma, dendrites and
synaptoneurosomes suggests the possibility that it plays
multiple roles in Ca2+ channel regulation. Moreover, its
localization within ER membrane and primary spatial ex-
pression in soma and dendrites are functionally
important for its regulation of ER-resident IP3R, and po-
tential regulation of TRPCs, which are localized mainly
in soma and dendrites [22–24].
In this study, we investigated the role of PERK in Gq
protein-coupled [Ca2+]i mobilization in primary cortical
neurons, and identified it as a negative regulator of
Fig. 5 Gq protein-coupled intracellular Ca
2+ ([Ca2+]i) mobilization is impaired in genetic Perk knockout primary cortical neurons. a Western blot
analysis confirmed almost complete knockdown of PERK in the cerebral cortex of BrPKO mice at postnatal day 0 (BrPKO: Nestin-Cre Perk-floxed;
*** p < 0.001, two-tailed student’s t-Test). b No difference in synapse density was observed between WT and BrPKO primary cortical neurons.
Representative image on the left shows the immunofluorescent staining of Synapsin 1(red) and MAP2 (green) in primary cortical neurons. Synapse
density quantification in the bar graph on the right represents pooled data from 3 mice per genotype (5 neurons were randomly picked for synapse
density quantification per animal, n = 15 for each genotype; WT and BrPKO neurons were cultured from the pups in the same litter; n.s. not significant,
two-tailed student’s t-Test). c DHPG stimulated [Ca2+]i rise is impaired in genetic Perk KO primary cortical neurons. In the representative graph on the
left, each Ca2+ trace represents the average of 8–10 neurons that were imaged from the same coverslip. Basal Ca2+ oscillation over 100 sec before
treatment and DHPG-stimulated [Ca2+]i rise over 200 sec were quantified by calculating the area under the curve (AUC). Final analysis is presented as
AUC/100 sec and shown in the bar graph on the right (WT n = 44, BrPKO n = 34; *** p < 0.001, two-tailed student’s t-Test)
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IP3R-dependent ER Ca
2+ release and a positive regulator
of receptor-operated Ca2+ entry. Our finding that inhib-
ition of PERK alters Ca2+ dynamics within a few minutes
after inhibitor application is inconsistent with the hy-
pothesis that these effects are mediated by changes in
protein translation. Moreover, it is unlikely that these
observations are due to off-target effects because genetic
ablation of Perk mimicked the impaired Gq protein-
coupled [Ca2+]i mobilization observed in pharmacologic-
ally PERK-inhibited neurons.
How then does PERK regulate these processes? We
speculate that PERK’s regulation of IP3R-dependent ER
Ca2+ release is mediated by its regulation of calcineurin,
a Ca2+/calmodulin-dependent protein phosphatase that
negatively regulates IP3R [25, 26]. PERK and calcineurin
have been shown to physically interact, which impacts
their individual enzymatic activities [27]. Moreover, in
pancreatic insulin-secreting β-cells, PERK positively
regulates calcineurin activity and calcineurin is a down-
stream mediator of PERK’s action on Ca2+-dependent
insulin secretion [10]. These results led us to speculate
that PERK might negatively regulate IP3R activity
through its positive regulation of calcineurin in pyram-
idal neurons.
For Gq/PLC coupled ROCE, the family of TRPC chan-
nels form nonselective receptor-operated Ca2+ channels
[28]. A number of intracellular signals generated down-
stream of Gq/PLC pathway have been shown to activate
TRPCs, which include increased PLC activity, generation
of DAG and internal Ca2+ store depletion [28]. Among
them, DAG is the only identified second messenger that
directly gates TRPC activity. DAG has been shown to ac-
tivate TRPC3/6/7 channels [29, 30] while inhibiting
TRPC5 channel activity [31]. Since PERK has an intrin-
sic DAG kinase activity of converting DAG into phos-
phatidic acid [32], it is possible that PERK regulates
TRPC activity by modulating intramembrane DAG
levels. In addition, it is also possible that PERK regu-
lates ROCE via its interaction with calcineurin. In neur-
onal PC12D cells, it has been shown that calcineurin is
recruited to the TRPC6 centered multiprotein complex
induced by M1 mAChR activation, and it is essential for
TRPC6 dephosphorylation and M1 mAChR dissociation
from the complex, suggesting that calcineurin might play
a regulatory role in receptor-operated TRPC6 activation
[33].
Receptor-operated and stored-operated Ca2+ entries
are closely related: store depletion is an integral compo-
nent of ROCE, and TRPCs have been suggested to be
the Ca2+ channels involved in both processes. Although
almost all of the TRPCs can be activated by store deple-
tion [34–41], there is accumulating evidence suggesting
that the regulation of TRPC3/6/7 [29, 30, 42] and
TRPC4/5 [43, 44] activities can also be store depletion-
independent. Our observation that acute PERK inhib-
ition impairs ROCE but not SOCE suggests that PERK’s
regulation of ROCE might be independent of internal
Ca2+ release.
Does PERK’s regulation of Gq protein-coupled [Ca
2+]i
mobilization play any physiological role in cognitive func-
tion? Previously we have observed significant working
memory impairment in forebrain-specific Perk KO mice
[7], and we speculate that PERK regulates working mem-
ory via its modulation of Gq protein-coupled Ca
2+ dynam-
ics in pyramidal neurons. Intracellular signaling pathways
initiated by muscarinic acetylcholine and metabotropic
glutamate receptors are critical for working memory, since
blockage of either receptor impairs working memory in
animals [45–48], and activation of either receptor is suffi-
cient to induce the Ca2+-activated nonselective cationic
current (ICAN) [4, 5] , which is essential for working mem-
ory. Gq protein-coupled [Ca
2+]i mobilization regulates
Fig. 6 Proposed model for PERK’s regulation of Gq protein-coupled Ca
2+ dynamics in pyramidal neurons. Upon extracellular ligand binding, Gq
protein-coupled receptor is activated, which subsequently activates Gq/PLC. Activated PLC hydrolyzes PIP2 into IP3 and DAG. Increased cytosol IP3
induces ER Ca2+ depletion by binding with ER-resident IP3R, which may activate PERK due to Ca
2+ dissociation from its regulatory domain in the
ER. Activated PERK may then restore ER Ca2+ level by inhibiting IP3R mediated ER Ca
2+ release and activating receptor-operated Ca2+ entry
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working memory in several ways. First, the induced [Ca2
+]i rise is known to activate several Ca
2+-dependent pro-
tein enzymes, including the phosphatase calcineurin, and
the kinases CaMKII and PKC, all of which have been
shown to regulate working memory capacity [49]. Sec-
ondly, the ICAN, which is identified as the ionic mechan-
ism underlying neuronal persistent firing [4], is Gq
protein and Ca2+-dependent [5]. Finally, Gq protein-
coupled [Ca2+]i rise has direct effects on intrinsic neuronal
excitability. It has been demonstrated that pharmaco-
logical activation of mGluR1 in prefrontal cortex pyram-
idal neurons triggers a biphasic electrical response-SK
channel-dependent neuronal hyperpolarization followed
by TRPC-dependent neuronal depolarization, and the
amplitude of both are regulated by the extent of [Ca2+]i
rise [50, 51]. Taken together, we speculate that PERK may
regulate working memory by modulating Gq protein-
coupled [Ca2+]i mobilization in pyramidal neurons.
Considering PERK’s role in eIF2α-dependent protein
synthesis and translational control, it has been hypothe-
sized that PERK’s regulation over memory flexibility and
mGluR1-dependent long-term depression is eIF2α-
dependent [8, 9]. However, genetic reduction of eIF2α
phosphorylation by single allele phosphorylation site
mutation of eIF2α [52], or knockdown of other eIF2α
kinases GCN2 [53] and PKR [54], lowers the threshold
for late phase long-term potentiation and facilitates
long-term memory storage, a phenotype that is absent in
forebrain-specific Perk knockout mice [8, 9]. Thus, it is
very likely that PERK imparts additional regulation on
cognition that is eIF2α-independent. This study’s discov-
ery of PERK-dependent regulation of Gq protein-coupled
Ca2+ dynamics in primary cortical neurons, together
with the earlier finding that PERK regulates Ca2+
dynamics-dependent working memory [7], supports the
above hypothesis. Further studies are required to eluci-
date the specific pathways that underlie PERK’s regula-
tion of intracellular Ca2+ dynamics.
As an eIF2α kinase, how did PERK evolve to be a
modulator of Gq protein-coupled Ca
2+ dynamics in pyr-
amidal neurons? We speculate that during early verte-
brate evolution, PERK first played an eIF2α-dependent
role in CNS. Given its localization on the ER, which is
the major organelle for intracellular Ca2+ storage, and its
regulation by ER/cytosolic Ca2+[10, 55], the constant
interaction with Ca2+ may have provided PERK the op-
portunity to evolve an additional function to regulate
intracellular Ca2+ dynamics through mechanism inde-
pendent of eIF2a and protein translation. The fact that
PERK is activated by ER Ca2+ depletion [55], and the
discoveries of PERK being a negative regulator of IP3R
and a positive regulator of ROCC shown herein, fit
well into this hypothesis: when ER Ca2+ stores are de-
pleted under physiological responses such as activation
of Gq protein-coupled receptor, PERK is activated due
to Ca2+ dissociation from its regulatory domain in the
ER, and it subsequently replenishes ER Ca2+ by inhibit-
ing IP3R mediated ER Ca
2+ release and activating
ROCE (Fig. 6).
Additional files
Additional file 1: Materials and methods for supplemental figures.
(DOCX 17 kb)
Additional file 2: Figure S1. PERK is expressed in synaptoneurosome.
A. Western blot analysis confirmed that the synaptoneurosome fraction
is enriched of presynaptic marker synaptotagmin, postsynaptic marker
NMDAR 2B, and clear of a nuclear marker CREB-1. Representative
western blot on the left shows the expression of fraction markers in
the homogenate and synaptoneurosome isolated from mice prefrontal
cortex. (H: homogenate; S: synaptoneurosome). The protein quantification
on the right represents pooled data from both genotypes (n = 6 for each
genotype; * p < 0.05; *** p < 0.001; two-tailed student’s t-Test). B. PERK signal
in synaptoneurosome is not due to rough ER contamination from soma.
The ratio of PERK’s expression in synaptoneurosome over homogenate
fraction is compared to that of a rough ER marker, Ribophorin 1. The
significant higher ratio of PERK suggests that the detection of PERK
signal in synaptoneurosome is not due to rough ER contamination from
soma. Representative western blot on the left shows the expression of
PERK and Ribophorin 1 in the homogenate and synaptoneurosomes
collected from wild-type mice’s prefrontal cortex. The quantification on the
right represents the ratio of each protein’s expression in synaptoneurosome
over homogenate fraction after actin normalization (* p < 0.05, two-tailed
student’s t-Test). (TIF 272 kb)
Additional file 3: Figure S2. DHPG induced Ca2+ rise in proximal
dendrites is impaired by acute PERK inhibition. Ca2+ level in the proximal
dendrites of primary cortical neurons in response to 50 μM DHPG
treatment. (DMSO n = 18, PI n = 16; ** p < 0.01, two-tailed student’s
t-Test). Cells were pretreated with 500 nM PERK inhibitor (PI) or
DMSO for 15 min before recording. In the representative graph on
the left, each Ca2+ trace represents the average of 6 proximal den-
drites from 6 individual neurons that were imaged from the same
coverslip. Basal Ca2+ oscillation over 100 sec before treatment and
DHPG-stimulated Ca2+ rise over 200 sec were quantified by calculating the
area under the curve (AUC). Final analysis is presented as AUC/100 sec and
shown in the bar graph on the right. (TIF 174 kb)
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